Abstract
Maternal body mass index is a key factor that essentially regulates pregnancy outcome with respect to maternal and neonatal health. Maternal bodies, whether underweight or obese during pregnancy, can significantly increase the risk of adverse outcomes for both mothers and newborns. Therefore, it is of interest to evaluate the impact of maternal BMI on pregnancy outcomes and feto-maternal complications related to various BMI categories in a tertiary care setting. Hence, we recruited 250 pregnant women and divided them into five subgroups based on their BMI. We collected data on pregnancy complications, modes of delivery and maternal and neonatal outcomes. We performed tests of significance between categories of BMI and clinical outcomes. Percentage distribution by BMI: normal weight 49.2%, underweight 28.4%, overweight 15.6%, obese 6% and morbidly obese 0.8%. There was significant variability in higher BMI with incidences of caesarean section, pre-eclampsia, gestational diabetes, and NICU admissions. Anaemia rates were higher in underweight women, whereas pregnancy and childbirth-related complications like PPH and macrosomia were more pronounced in obese women. Severe extremes in BMI are associated with drastic adverse consequences, both for maternal and neonatal outcomes. Effective weight management is therefore key to achieving favourable pregnancy outcomes. Low BMI increases the risk of preterm birth and anaemia; high BMI raises the risk of gestational diabetes and hypertensive disorders. Key strategies include preconception counselling, tailored nutrition and physical activity.
Keywords: Maternal BMI, pregnancy outcomes, feto-maternal complications, caesarean section, pre-eclampsia, gestational diabetes, underweight
Background:
Indeed, body mass index is a really crucial measurement during pregnancy in order to indicate health risks. Adverse maternal and fetal outcomes have been associated with low weight and overweight. According to the WHO, malnutrition embraces disorders classified as underweight and overweight disorders, over nutrition being the later one; thus, they present great public health problems in almost all countries worldwide [1, 2]. Maternal BMI is also significantly influential on the outcome of a pregnancy. Pregnancy complications, including lower birth weights resulting in preterm babies and maternal anaemia, are likely to be experienced by women who were underweight prior to becoming pregnant [3]. Indeed, recurrent issues of food insecurity and inadequate prenatal care in developing countries mean that a high percentage of women in these countries remain at low weights [4, 5]. Overweight and obese women, on the other hand, are at higher risk for gestational diabetes mellitus, hypertensive disorders, pre-eclampsia and caesarean delivery. Additionally, infants born to overweight and obese mothers are more likely to experience adverse outcomes such as macrosomia and NICU admission [6, 7, 8- 9]. Under nutrition and obesity coexist among the rural and semi-urban areas in India. Recent estimates indicate that 23% of Indian women are underweight, while about 20% are obese or overweight. This reflects double malnutrition in their country, as revealed by recent trends [10, 11]. Rapid nutritional transitions and socioeconomic inequities tend to amplify this trend in nutritional deficiencies in developing countries. Some have limited access to nutritious food; others are increasingly adhering to a Westernized diet consisting of high-calorie, nutrient-deficient processed foods that contribute to obesity [12]. Today, it has become undeniable that increasing rates of obesity and its comorbidities in populations from the developing world, especially rural, are a point of concern [13]. Therefore, it is of interest to demonstrate how maternal nutrition influences pregnancy outcomes and offer valuable suggestions for health care interventions tailored to women with varying BMI levels.
Materials and Methods:
This was a prospective observational study conducted in the Obstetrics and Gynaecology Department of Obstetrics and Gynaecology at District General Hospital Piparia from January 2019 to June 2020, following ethical approval. The study enrolled a total of 250 pregnant women with singleton pregnancies who presented during their first trimester. BMI was calculated using the Quetelet index (weight in kg/height in meters squared), and participants were categorized into underweight (<18.5), normal weight (18.5-24.9), overweight (25.0-29.9), obese (30.0-39.9), and morbidly obese (>40). Inclusion criteria included women in their first trimester, aged 18-40 years, with no pre-existing systemic diseases and the exclusion criteria comprised of women with multiple pregnancies, those presenting after the first trimester, and women with chronic medical conditions such as diabetes or cardiac diseases. Data on maternal demographics, BMI, pregnancy complications (e.g., anaemia, GDM, pre-eclampsia), mode of delivery and neonatal outcomes (e.g., birth weight, NICU (Neonatal Intensive Care Unit) admissions) were collected. Statistical tests included Kruskal-Wallis One-way ANOVA, chi-square tests and student unpaired t-tests. A p-value ≤ 0.05 was considered significant.
Results:
Table 1 Distribution of Population Based on BMI. Table 2 presents the mean age of women in each BMI category and the percentage of women in the 21-25 years age group. The mean age increased with higher BMI categories, with the morbidly obese group having the highest mean age (31.50 years). Table 3 highlights the variation in pregnancy history among different BMI categories, with obese women more likely to be multigravida. Table 4 shows the distribution of pregnancy outcomes such as preterm, term, post-term deliveries and abortion rates across BMI categories. (Table 5) outlines the mode of delivery (vaginal vs. caesarean) in each BMI category. Vaginal deliveries were more common in the underweight and normal BMI groups, while caesarean sections were significantly more frequent in the obese (53.3%) and morbidly obese (50%) groups, highlighting the increased risk of surgical intervention with higher BMI. Table 6 lists NICU admissions and incidences of macrosomia by BMI category. Table 7 provides data on antepartum complications, including anaemia, pre-eclampsia, gestational diabetes mellitus (GDM) and antepartum haemorrhage (APH). Pre-eclampsia and GDM were significantly higher in the obese and overweight groups, with obesity being associated with a particularly high rate of GDM (26.67%). Table 8 highlights postpartum complications such as postpartum haemorrhage (PPH) and wound gaping.
Table 1. Demonstrates distribution of the study participants across different BMI categories.
| BMI Category | No. of Women | % of Total |
| Underweight | 71 | 28.40% |
| Normal | 123 | 49.20% |
| Overweight | 39 | 15.60% |
| Obese | 15 | 6.00% |
| Morbidly Obese | 2 | 0.80% |
Table 2. Mean age and age group distribution by BMI.
| BMI Category | Mean Age (years) | Age Group (21-25 years)% |
| Underweight | 23.83 | 47.89% |
| Normal | 24.65 | 34.96% |
| Overweight | 24.59 | 51.28% |
| Obese | 25.33 | 33.33% |
| Morbidly Obese | 31.5 | - |
Table 3. Gravida status by BMI.
| BMI Category | Primigravida (%) | Multigravida (%) |
| Underweight | 45.07% | 54.93% |
| Normal | 47.15% | 52.85% |
| Overweight | 53.85% | 46.15% |
| Obese | 26.67% | 73.33% |
Table 4. Pregnancy outcomes by BMI.
| BMI Category | Preterm (%) | Term (%) | Post-term (%) | Abortion (%) |
| Underweight | 14.08% | 71.80% | 11.20% | 2.82% |
| Normal | 14.63% | 74.79% | 9.75% | 0.81% |
| Overweight | 15.38% | 64.10% | 12.80% | 7.69% |
| Obese | 13.33% | 60.00% | 13.33% | 13.33% |
Table 5. Mode of delivery by BMI.
| BMI Category | Vaginal (%) | Caesarean (%) |
| Underweight | 71.80% | 25.40% |
| Normal | 68.30% | 30.90% |
| Overweight | 51.30% | 41.00% |
| Obese | 33.30% | 53.30% |
| Morbidly obese | - | 50.00% |
Table 6. NICU admissions and neonatal complications by BMI.
| BMI Category | NICU Admissions (%) | Macrosomia (%) |
| Underweight | 2.80% | - |
| Normal | 3.30% | 2.46% |
| Overweight | 20.50% | 11.11% |
| Obese | 26.70% | 15.38% |
Table 7. Antepartum complications by BMI.
| BMI Category | Anaemia (%) | Pre-eclampsia (%) | GDM (%) | APH (%) |
| Underweight | 23.94% | 21.13% | 2.82% | 4.23% |
| Normal | 5.69% | 22.76% | 3.25% | 4.88% |
| Overweight | 7.69% | 38.46% | 10.26% | 10.26% |
| Obese | 6.67% | 40.00% | 26.67% | 13.33% |
Discussion:
In this study, we aimed to assess the impact of maternal BMI on pregnancy outcomes in the Indian population. Our findings align with recent research that both low and high BMI levels significantly affect maternal and neonatal health. The data showed that being underweight or overweight during pregnancy is linked to a higher risk of problems during labour and delivery, including preeclampsia, gestational diabetes mellitus (GDM), caesarean sections (CS) and bad outcomes for the baby, such as macrosomia and NICU admissions. The majority of our study population had a normal BMI (49.2%), comparable to other studies in India that report normal BMI prevalence rates ranging from 40% to 60% [14]. However, the proportion of underweight women (28.4%) remains significant in rural populations, reflecting the continued prevalence of under nutrition in certain areas of India [15].
On the other hand, the nutritional transition and lifestyle changes in rural settings likely contribute to the increasing prevalence of obesity and overweight [16].
Underweight women were more likely to experience anaemia (23.94%), as seen in other studies evaluating maternal nutrition in developing countries [17]. Anaemia in pregnancy can lead to low birth weight and preterm delivery, both of which were observed at higher rates in this group [18]. Similarly, studies have shown that underweight women face a higher risk of preterm labour and low birth weight infants due to insufficient nutritional reserves [19]. On the other hand, overweight and obese women showed higher incidences of hypertensive disorders, such as pre-eclampsia (38.46% in overweight and 40% in obese women), which aligns with global trends [20]. A meta-analysis demonstrated that the risk of pre-eclampsia doubles with each 5-7 kg/m2 increase in BMI [21]. Insulin resistance, systemic inflammation and vascular dysfunction commonly observed in obese pregnant women contribute to this heightened risk [22]. Gestational diabetes was also notably higher in overweight (10.26%) and obese (26.67%) women [23]. This finding is consistent with recent research indicating that maternal obesity is a major risk factor for the development of GDM, with overweight women being three times more likely to develop the condition compared to women with normal BMI [24]. GDM not only increases the risk of macrosomia but also predisposes mothers to type 2 diabetes later in life [25]. One of the most significant findings of our study is the strong association between maternal BMI and mode of delivery. Caesarean sections were more common in obese women (53.3%) compared to those with normal BMI (30.9%) [26]. Various studies consistently report an increased rate of caesarean sections (CS) in overweight and obese women [27]. The reasons for this trend include fetal macrosomia, prolonged labour and dysfunctional uterine contractions in obese women [28]. Furthermore, literature suggests that obese women are more likely to have labour-induced and less likely to have a successful vaginal delivery, which further elevates CS rates [29]. Efforts to optimize maternal BMI through targeted interventions such as preconception counselling, weight management programs and regular prenatal care are crucial for improving pregnancy outcomes. Addressing both under nutrition and obesity among women of reproductive age can significantly reduce the burden of adverse maternal and neonatal outcomes. Public health policies should focus on increasing access to nutritional education and prenatal care in rural areas, promoting healthy weight gain during pregnancy and managing pre-existing nutritional deficits. By prioritizing maternal health, we can ensure better outcomes for both mothers and their babies, reducing the long-term impact of malnutrition on future generations [30]. The mechanism underlying this association is unclear and is worthy of further investigation [31].
Conclusion:
The significant impact of maternal BMI on both maternal and neonatal outcomes in Indian population is of interest. Data shows that both underweight and obesity pose substantial risks during pregnancy, affecting maternal health through complications such as anaemia, pre-eclampsia and gestational diabetes. Extreme BMI also affects the outcome of delivery, with higher rates of caesarean sections and a higher risk of neonatal complications like macrosomia and NICU admissions.
Table 8. Postpartum complications by BMI.
| BMI category | PPH (%) | Wound gaping (%) | Total complications (%) |
| Underweight | 2.82% | 8.45% | 15.50% |
| Normal | 4.07% | 4.07% | 10.60% |
| Overweight | 15.38% | 15.38% | 43.60% |
| Obese | 20 |
Edited by Hiroj Bagde
Citation: Gandhi et al. Bioinformation 20(10):1257-1260(2024)
Declaration on Publication Ethics: The author's state that they adhere with COPE guidelines on publishing ethics as described elsewhere at https://publicationethics.org/. The authors also undertake that they are not associated with any other third party (governmental or non-governmental agencies) linking with any form of unethical issues connecting to this publication. The authors also declare that they are not withholding any information that is misleading to the publisher in regard to this article.
Declaration on official E-mail: The corresponding author declares that official e-mail from their institution is not available for all authors.
License statement: This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License
Comments from readers: Articles published in BIOINFORMATION are open for relevant post publication comments and criticisms, which will be published immediately linking to the original article without open access charges. Comments should be concise, coherent and critical in less than 1000 words.
Bioinformation Impact Factor:Impact Factor (Clarivate Inc 2023 release) for BIOINFORMATION is 1.9 with 2,198 citations from 2020 to 2022 taken for IF calculations.
Disclaimer:The views and opinions expressed are those of the author(s) and do not reflect the views or opinions of Bioinformation and (or) its publisher Biomedical Informatics. Biomedical Informatics remains neutral and allows authors to specify their address and affiliation details including territory where required. Bioinformation provides a platform for scholarly communication of data and information to create knowledge in the Biological/Biomedical domain.
References
- 1. https://www.who.int/
- 2.Black RE, et al. The Lancet. . 2013;382:427. [Google Scholar]
- 3.O'Brien TE, et al. Epidemiology. . 2003;14:368. [Google Scholar]
- 4.Han Z, et al. Int J Epidemiol. . 2011;40:65. doi: 10.1093/ije/dyq195. [DOI] [PubMed] [Google Scholar]
- 5.Yazdani S, et al. BMC Res Notes. . 2012;5:34. doi: 10.1186/1756-0500-5-34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Grieger JA, et al. PLoS Med. . 2018;15:e1002710. doi: 10.1371/journal.pmed.1002710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rasmussen KM, Yaktine AL. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington (US): National Academies Press; 2009. [PubMed] [Google Scholar]
- 8.Papadopoulou SK, et al. Medicina (Kaunas). . 2023;59:664. [Google Scholar]
- 9.Leddy MA, et al. Rev Obstet Gynecol. . 2008;1:170. [PMC free article] [PubMed] [Google Scholar]
- 10.Al-Kibria GM, et al. Glob Health Res Policy. . 2019;4:24. doi: 10.1186/s41256-019-0117-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Sukumar M, et al. Cureus. . 2024;16:e59788. doi: 10.7759/cureus.59788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pradeepa R, et al. Indian J Med Res. . 2015;142:139. doi: 10.4103/0971-5916.164234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Tham KW, et al. Obes Rev. . 2023;24:e13520. doi: 10.1111/obr.13520. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sushmitha S, et al. Cureus. . 2023;15:e40874. doi: 10.7759/cureus.40874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Samuel TM, et al. Nutrients. . 2019;11:1811. [Google Scholar]
- 16.Nurul-Farehah S, Rohana AJ. Malays Fam Physician. . 2020;15:34. [PMC free article] [PubMed] [Google Scholar]
- 17.Motedayen M, et al. Int J Reprod Biomed. . 2019;17:463. doi: 10.18502/ijrm.v17i7.4857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jayasinghe IU, et al. BMC Pregnancy Childbirth. . 2023;23:231. doi: 10.1186/s12884-023-05548-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Walsh SW. Trends Endocrinol Metab. . 2007;18:365. doi: 10.1016/j.tem.2007.09.003. [DOI] [PubMed] [Google Scholar]
- 20.Kim W, et al. PLoS One. . 2019;14:e0225955. doi: 10.1371/journal.pone.0225955. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Liang CC, et al. Biomed J. . 2020;43:476. doi: 10.1016/j.bj.2019.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Berendzen JA, Howard CB. Tenn Med. . 2013;106:35. [PubMed] [Google Scholar]
- 23.Bjorklund J, et al. PLoS One. . 2022;17:e0263685. doi: 10.1371/journal.pone.0263685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Slabuszewska-Józwiak A, et al. J Clin Med. . 2021;10:675. doi: 10.3390/jcm10040675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Santangeli L, et al. Best Pract Res Clin Obstet Gynaecol. . 2015;29:438. doi: 10.1016/j.bpobgyn.2014.10.009. [DOI] [PubMed] [Google Scholar]
- 26.Isgren AR, et al. J Pediatr Adolesc Gynecol. . 2019;32:139. doi: 10.1016/j.jpag.2018.11.003. [DOI] [PubMed] [Google Scholar]
- 27.Gaudet L, et al. Biomed Res Int. . 2014;2014:640291. doi: 10.1155/2014/640291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Wanjari M, et al. Neurosurg Rev. . 2024;47:532. doi: 10.1007/s10143-024-02778-2. [DOI] [PubMed] [Google Scholar]
- 29.Aganze JM, et al. Neurosurg Rev. . 2024;47:561. doi: 10.1007/s10143-024-02779-1. [DOI] [PubMed] [Google Scholar]
- 30.Maulani C, et al. F1000Res. . 2021;10:643. doi: 10.12688/f1000research.53823.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Khashan AS, Kenny LC. Eur J Epidemiol. . 2009;24:697. doi: 10.1007/s10654-009-9375-2. [DOI] [PubMed] [Google Scholar]
